Schedule 13G ownership disclosure

XILIO THERAPEUTICS INC

Security class unavailable · CUSIP: 98422T100

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.8300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-23-001091
Form type
SC 13G
Filer
Octagon Capital Advisors LP
CIK
CIK 1839435
Filed
Jan 25, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub